Consistent with our present findings, HU and AZT, which are both independent of dCK activity status were previously found to elicit a synergistic cytotoxic activity against human acute lymphoblastic and chronic myelogenous leukemia cell line models42,43. This evidence concerns the gene DCK and chronic myelogenous leukemia, BCR-ABL1 positive.